Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.Eight-day four-board three-dimensional communication: the company's operation is normal, and the internal and external operating environment has not changed significantly. On December 9, December 10 and December 11, 2024, the company's closing price increase deviated by more than 20% for three consecutive trading days, which belongs to the abnormal fluctuation of stock trading. The company's operation is normal, and the internal and external operating environment has not changed significantly. The Company has no other circumstances that violate the provisions on fair disclosure of information.
Zhongjin Chongqing Liangjiang REIT is listed on the Shanghai Stock Exchange, and Zhongjin Chongqing Liangjiang REIT is listed on the Shanghai Stock Exchange. This is the first public offering REIT of state-owned enterprises in the west and the first industrial park REIT in the west. According to the data, the fund has 4 assets in the pool, all located in Chongqing Liangjiang Digital Economy Industrial Park, including Pisces Project, Gemini Project, Phoenix Project and Tuo D Phase I D2 Project, with a total construction area of about 243,700 square meters, and the operation of infrastructure assets is mature and stable. (CSI Taurus)Wells Fargo: Reduce the target price of Dow Chemical from $60 to $55, and maintain the "overweight" rating.South Korean Finance Minister and US Treasury Secretary Yellen confirmed that they will work closely together.
Syrian opposition forces claimed to have taken control of the eastern Syrian city of Deir ez-Zor. According to Al Jazeera and Arabiya TV, on the 10th local time, Hassan Abdel Ghani, commander of Syrian opposition forces, said that "the eastern Syrian city of Deir ez-Zor has been completely controlled".Trump said that he chose Andrew Feargus, Commissioner of the US Federal Trade Commission (FTC), as the FTC chairman.Liaoning Energy: Guo Hongbo, the chairman of the board of directors, resigned due to job change. Liaoning Energy (600758) announced on the evening of December 11th that Guo Hongbo applied to resign as the chairman, director and all the special committees under the board of directors due to job change. After resigning, Guo Hongbo no longer holds any position in the company.